SOP - Cytotoxins and Antineoplastic Drugs: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 141: | Line 141: | ||
*[[User:Iharvey|Iharvey]] ([[User talk:Iharvey|talk]]) 21:12, 10 November 2016 (UTC) | *[[User:Iharvey|Iharvey]] ([[User talk:Iharvey|talk]]) 21:12, 10 November 2016 (UTC) | ||
* [[User:Elhabbal|Elhabbal]] ([[User talk:Elhabbal|talk]]) 22:02, 12 June 2017 (UTC) | *[[User:Elhabbal|Elhabbal]] ([[User talk:Elhabbal|talk]]) 22:02, 12 June 2017 (UTC) | ||
*[[User:Reddj|Reddj]] ([[User talk:Reddj|talk]]) | |||
*[[User:Mollyec|Mollyec]] ([[User talk:Mollyec|talk]]) 16:48, 6 June 2022 (UTC) | |||
Principal Investigator Revision Date | Principal Investigator Revision Date | ||
Laboratory SOP: Cytotoxins 4 Revision Date: 6/12/2014 | Laboratory SOP: Cytotoxins 4 Revision Date: 6/12/2014 | ||